Larazotide acetate for treatment of celiac disease: A systematic review and meta-analysis of randomized controlled trials

•Larazotide acetate is a novel, synthetic, eight-amino acid peptide that antagonizes zonulin, a key tight junction protein implicated in celiac disease pathogenesis.•Larazotide acetate is safe and superior to placebo in alleviating gastrointestinal symptoms among patients undergoing gluten challenge...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinics and research in hepatology and gastroenterology 2022-01, Vol.46 (1), p.101782-101782, Article 101782
Hauptverfasser:	Hoilat, Gilles Jadd, Altowairqi, Abdulaziz Khalaf, Ayas, Mohamad Fekredeen, Alhaddab, Noor Tariq, Alnujaidi, Razan Abdulkarim, Alharbi, Hadeel Abdulaziz, Alyahyawi, Naseem, Kamal, Aminah, Alhabeeb, Habeeb, Albazee, Ebraheem, Almustanyir, Sami, Abu-Zaid, Ahmed
Format:	Artikel
Sprache:	eng
Schlagworte:	AT-1001 Celiac disease Celiac Disease - diagnosis Diet, Gluten-Free Double-Blind Method Gluten Glutens - adverse effects Humans Larazotide acetate Meta-analysis Oligopeptides - therapeutic use Randomized Controlled Trials as Topic
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!